IMU 1.41% 7.0¢ imugene limited

Ann: Phase 1 onCARlytics Trial Advances to Combination Arm, page-93

  1. 6,587 Posts.
    lightbulb Created with Sketch. 4327
    Just musing here. IF the OnCarlytics/Blincyto trial yields great outcome for the patients, ie CRs and strong PRs, would Amgen decides:

    'Nope, we don't want anything to do with treating 90% of the solid cancer market'
    or
    'FECK! Let's BUY Imugene or BEG them to give us a deal'

    Which is the most likely scenario? And I stress again, only IF the trial outcome is successful.

    And then of course there is that OnCarlytics/Azer-cel trial. If is successful, then whoever comes after that to do a deal will literally have to go on their knees to beg IMU to throw a bit of bone over to them for IMU won't really need any of them anymore by then. In view of that, I believe if the above OnCarlytics/Blincyto successful scenario were to come to pass, I bet Amgen would not wait nor hesitate to ring IMU. In fact, they might panic if IMU did not pick up the phone quick enough

    OK, musing over
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.001(1.41%)
Mkt cap ! $512.3M
Open High Low Value Volume
7.0¢ 7.1¢ 6.8¢ $922.0K 13.28M

Buyers (Bids)

No. Vol. Price($)
9 702419 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.1¢ 1365317 9
View Market Depth
Last trade - 16.10pm 24/05/2024 (20 minute delay) ?
Last
7.0¢
  Change
-0.001 ( 1.69 %)
Open High Low Volume
7.0¢ 7.1¢ 6.8¢ 5455105
Last updated 15.59pm 24/05/2024 ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.